awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38656760-8E7A9087-CA4D-41E3-894C-BA66ED059820
Q38656760-8E7A9087-CA4D-41E3-894C-BA66ED059820
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38656760-8E7A9087-CA4D-41E3-894C-BA66ED059820
Targeted therapy for renal cell carcinoma: focus on 2nd and 3rd line.
P2860
Q38656760-8E7A9087-CA4D-41E3-894C-BA66ED059820
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38656760-8E7A9087-CA4D-41E3-894C-BA66ED059820
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b5e32bc300adfa786d814a0055d43a63207ccde1
P2860
SWITCH: A Randomised, Sequential, Open-label Study to Evaluate the Efficacy and Safety of Sorafenib-sunitinib Versus Sunitinib-sorafenib in the Treatment of Metastatic Renal Cell Cancer.